These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis. Kassubek J; Müller HP Expert Rev Neurother; 2020 Mar; 20(3):237-249. PubMed ID: 31937156 [No Abstract] [Full Text] [Related]
6. Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis. Van Weehaeghe D; Ceccarini J; Delva A; Robberecht W; Van Damme P; Van Laere K J Nucl Med; 2016 Aug; 57(8):1238-43. PubMed ID: 26940764 [TBL] [Abstract][Full Text] [Related]
7. Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosis. Pradat PF; El Mendili MM Biomed Res Int; 2014; 2014():467560. PubMed ID: 24949452 [TBL] [Abstract][Full Text] [Related]
8. Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An Zanovello M; Sorarù G; Campi C; Anglani M; Spimpolo A; Berti S; Bussè C; Mozzetta S; Cagnin A; Cecchin D J Nucl Med; 2022 May; 63(5):777-784. PubMed ID: 34503963 [TBL] [Abstract][Full Text] [Related]